×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Modérateurs : Pr Jérôme Alexandre & Dr Enora Laas


Cas clinique :  

18:30
Mise en pratique des données de DESKTOP III :

 - Recommandations de surveillance à la fin du traitement initial - Pr Jérôme Alexandre

- Nouvelles stratégies chirurgicales en rechute - Dr Enora Laas
 
19:10
Espérance de vie des patientes sous iPARP : quels nouveaux enjeux en maintenance ?
Dr Manuel Rodrigues
 
19:35
Quelles possibilités de suivi des patientes sous iPARP en pratique courante ?
Mme Pascale Dielenseger
19:45
Discussion Q&A
 

 

Shooting date : 2021-06-22
Last update : 2021-06-29
1 comment
Join the Discussion
  • l D. quand pourra-t-on avoir le replay? Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Wednesday, March 12th 2025 from 01pm to 01:45pm (GMT+1)
    Honolulu : Wednesday, March 12th 2025 from 02am to 02:45am (GMT+1)
    San Francisco : Wednesday, March 12th 2025 from 04am to 04:45am (GMT+1)
    New York : Wednesday, March 12th 2025 from 07am to 07:45am (GMT+1)
    Buenos Aires : Wednesday, March 12th 2025 from 09am to 09:45am (GMT+1)
    London / Dublin : Wednesday, March 12th 2025 from 12pm to 12:45pm (GMT+1)
    Paris / Berlin : Wednesday, March 12th 2025 from 01pm to 01:45pm (GMT+1)
    Istanbul : Wednesday, March 12th 2025 from 02pm to 02:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 12th 2025 from 04pm to 04:45pm (GMT+1)
    Bangkok : Wednesday, March 12th 2025 from 07pm to 07:45pm (GMT+1)
    Shanghai : Wednesday, March 12th 2025 from 08pm to 08:45pm (GMT+1)
    Tokyo : Wednesday, March 12th 2025 from 09pm to 09:45pm (GMT+1)
    Sydney : Wednesday, March 12th 2025 from 10pm to 10:45pm (GMT+1)
    Wellington : Thursday, March 13th 2025 from 12am to 12:45am (GMT+1)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l'endomètre avancé dMMR : quelle stratégie en 2025 ? (épisode 1)

    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 07am to 08:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 09am to 10:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 09pm to 10:30pm (GMT+1)
    Bangkok : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 03am to 04:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 05am to 06:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, November 16th 2022 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, November 16th 2022 from 09am to 10:30am (GMT+1)
    New York : Wednesday, November 16th 2022 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, November 16th 2022 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, November 16th 2022 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, November 16th 2022 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, November 16th 2022 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, November 16th 2022 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, November 17th 2022 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, November 17th 2022 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, November 17th 2022 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, November 17th 2022 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, November 17th 2022 from 05am to 06:30am (GMT+1)

    Cancer de l’ovaire et iPARP

    Share
    Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, February 7th 2024 from 07am to 08:30am (GMT+1)
    San Francisco : Wednesday, February 7th 2024 from 09am to 10:30am (GMT+1)
    New York : Wednesday, February 7th 2024 from 12pm to 01:30pm (GMT+1)
    Buenos Aires : Wednesday, February 7th 2024 from 02pm to 03:30pm (GMT+1)
    London / Dublin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Istanbul : Wednesday, February 7th 2024 from 07pm to 08:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, February 7th 2024 from 09pm to 10:30pm (GMT+1)
    Bangkok : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
    Shanghai : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
    Tokyo : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
    Sydney : Thursday, February 8th 2024 from 03am to 04:30am (GMT+1)
    Wellington : Thursday, February 8th 2024 from 05am to 06:30am (GMT+1)

    Toxicités hématologiques des inhibiteurs de PARP

    Regards croisés oncologue-hématologue-interniste

    Share
    Scroll Up